Spray Venture Partners focuses exclusively on contributing capital and expertise to emerging healthcare technology companies.
Business Model:
Revenue: $6.3M
Employees: 2-10
Address: 2330 Washington St
City: Newton
State: MA
Zip: 02462
Country: US
Spray Venture Partners focuses exclusively on contributing capital and expertise to emerging healthcare technology companies. They work closely with clinical and technical founders to create companies that develop, market and deploy innovative technologies to meet major unmet healthcare needs.
Contact Phone:
+16173326060
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2004 | Facet Solutions | Series A | - |
10/2009 | Direct Flow Medical | Series C | 40M |
9/2010 | Tryton Medical | Series D | 20M |
5/2007 | Interlace Medical | Series B | 3M |
7/2008 | Interlace Medical | Series B | 7M |
3/2000 | Intrinsic Therapeutics | Series A | - |
8/2007 | Leptos Biomedical | Series C | 20M |
3/2012 | Solace Therapeutics | Equity | 7M |
8/2005 | Direct Flow Medical | Series A | 8.4M |
1/2001 | Intrinsic Therapeutics | Series B | 7.2M |
1/2011 | PneumRx | Venture Round | 0 |
10/2013 | Conventus Orthopaedics | Venture Round | 0 |
6/2009 | Facet Solutions | Debt Financing | 4.1M |
3/2007 | PneumRx | Series B | 0 |
6/2002 | Confluent Surgical | Series C | 20M |
1/2013 | Tryton Medical | Unattributed | 24M |
10/2007 | Direct Flow Medical | Series B | 27M |
2/2010 | Intrinsic Therapeutics | Venture Round | 18M |
12/2005 | Facet Solutions | Series B | 16.5M |
12/2002 | Intrinsic Therapeutics | Series C | 25M |
10/2003 | Cotherix | Series C | 55M |
5/2010 | TearScience | Series C | 44.5M |
8/2006 | Solace Therapeutics | Series B | 3M |
7/2009 | Interlace Medical | Series C | 20.5M |
9/2007 | Intrinsic Therapeutics | Series D | 21M |
4/2012 | Direct Flow Medical | Venture Round | 0 |
8/2006 | Interlace Medical | Series A | 750k |
1/2007 | TearScience | Series B | 15.1M |
7/2005 | TearScience | Series A | 100k |
4/2008 | Tryton Medical | Series C | 14M |
10/2013 | Conventus Orthopaedics | Venture Round | 0 |
1/2013 | Tryton Medical | Venture Round | 0 |
4/2012 | Direct Flow Medical | Venture Round | 0 |
3/2012 | Solace Therapeutics | Venture Round | 0 |
1/2011 | PneumRx | Venture Round | 0 |
9/2010 | Tryton Medical | Series D | 0 |
5/2010 | TearScience | Series C | 0 |
2/2010 | Intrinsic Therapeutics | Venture Round | 0 |
10/2009 | Direct Flow Medical | Series C | 0 |
7/2009 | Interlace Medical | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|